CA-170

Manufacturer	MedChem Express
Category	Oncology By Cell Type Carcinoma Hematology Lymphoma Myelofibrosis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	10 mM/1 mL
Item no.	HY-101093-10mM
Targets	PD-1/PD-L1
CASRN	1673534-76-3
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	CA-170 is an orally delivered dual inhibitor of VISTA and PD-L1. CA-170 exhibits potent rescue of proliferation and effector functions of T cells inhibited by PD-L1/L2 and VISTA with selectivity over other immune checkpoint proteins as well as a broad panel of receptors and enzymes[1][2].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
Molecular Weight	360.32
Clinical Information	No Development Reported
Solubility	DMSO : 28.5 mg/mL (ultrasonic; warming)
Pathway	Immunology/Inflammation
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-101093-10mM-safety-datasheet.pdf